Activist & passive stakes
Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
Amendments only.1–9 of 9
- PassiveAmendment 1Nov 14, 2026Coastlands Capital LP6.19% · 3,653,440 shSEC
- PassiveAmendment 1Nov 14, 2026Coastlands Capital LP9.99% · 5,052,055 shSEC
- PassiveAmendment 1Nov 14, 2026Coastlands Capital LP9.99% · 731,573 shSEC
- PassiveAmendment 1Nov 14, 2026Coastlands Capital LP9.99% · 422,716 shSEC
- PassiveAmendment 1Nov 14, 2026Coastlands Capital LP9.99% · 10,719,139 shSEC
- PassiveAmendment 2Nov 14, 2026Coastlands Capital LP9.99% · 6,328,175 shSEC
- PassiveAmendment 1Nov 14, 2026Coastlands Capital LP9.99% · 3,803,851 shSEC
- PassiveAmendment 4Nov 13, 2026Cohen & Steers, Inc.7.72% · 32,846,317 shSEC
- PassiveAmendment 2Nov 5, 2026Fmr Llc9.9% · 15,811,950 shSEC
| Filing | Symbol | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|---|
PassiveAmendment 1 | WHWK | Coastlands Capital LP in Whitehawk Therapeutics, Inc. | 6.19% | 3,653,440 | Nov 14, 2026 | SEC |
PassiveAmendment 1 | NERV | Coastlands Capital LP in Minerva Neurosciences, Inc. | 9.99% | 5,052,055 | Nov 14, 2026 | SEC |
PassiveAmendment 1 | XLO | Coastlands Capital LP in Xilio Therapeutics, Inc. | 9.99% | 731,573 | Nov 14, 2026 | SEC |
PassiveAmendment 1 | ELOX | Coastlands Capital LP in Eloxx Pharmaceuticals, Inc. | 9.99% | 422,716 | Nov 14, 2026 | SEC |
PassiveAmendment 1 | XFOR | Coastlands Capital LP in X4 Pharmaceuticals, Inc. | 9.99% | 10,719,139 | Nov 14, 2026 | SEC |
PassiveAmendment 2 | CAMP | Coastlands Capital LP in CAMP4 Therapeutics Corporation | 9.99% | 6,328,175 | Nov 14, 2026 | SEC |
PassiveAmendment 1 | ANTX | Coastlands Capital LP in AN2 Therapeutics, Inc. | 9.99% | 3,803,851 | Nov 14, 2026 | SEC |
PassiveAmendment 4 | CCI | Cohen & Steers, Inc. in Crown Castle Inc. | 7.72% | 32,846,317 | Nov 13, 2026 | SEC |
PassiveAmendment 2 | FSLY | Fmr Llc in Fastly Inc | 9.9% | 15,811,950 | Nov 5, 2026 | SEC |